Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter W Laird

Showing results (101-110 of 183) with videos related to

Pageof 19
Sort By:
Cancer Research|August 30, 2022
High-Resolution Profiling of Lung Adenocarcinoma Identifies Expression Subtypes with Specific Biomarkers and Clinically Relevant VulnerabilitiesWhijae Roh, Yifat Geffen, Hongui Cha, et al.
JCO Precision Oncology|October 5, 2020
Systematic Assessment of Tumor Purity and Its Clinical ImplicationsSyed Haider, Svitlana Tyekucheva, Davide Prandi, et al.
Gastroenterology|October 5, 2014
Association between molecular subtypes of colorectal cancer and patient survivalAmanda I Phipps, Paul J Limburg, John A Baron, et al.
Theranostics|May 1, 2019
Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA)Wenhua Liang, Yue Zhao, Weizhe Huang, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 16, 2011
Altered folate availability modifies the molecular environment of the human colorectum: implications for colorectal carcinogenesisPetr Protiva, Joel B Mason, Zhenhua Liu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 30, 2015
Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive TumorsA Joan Levine, Amanda I Phipps, John A Baron, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 7, 2011
Cancer risks for the relatives of colorectal cancer cases with a methylated MLH1 promoter region: data from the Colorectal Cancer Family RegistryA Joan Levine, Aung Ko Win, Daniel D Buchanan, et al.
Genome Research|June 11, 2011
Genome-scale analysis of aberrant DNA methylation in colorectal cancerToshinori Hinoue, Daniel J Weisenberger, Christopher P E Lange, et al.
Nature Genetics|November 29, 2011
Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domainsBenjamin P Berman, Daniel J Weisenberger, Joseph F Aman, et al.
International Journal of Cancer|January 7, 2009
The methylenetetrahydrofolate reductase C677T mutation induces cell-specific changes in genomic DNA methylation and uracil misincorporation: a possible molecular basis for the site-specific cancer risk modificationKyoung-Jin Sohn, Hyeran Jang, Mihaela Campan, et al.
Pageof 19

Showing results (101-110 of 183) with videos related to

Sort By:
Pageof 19
Cancer Research|August 30, 2022
High-Resolution Profiling of Lung Adenocarcinoma Identifies Expression Subtypes with Specific Biomarkers and Clinically Relevant VulnerabilitiesWhijae Roh, Yifat Geffen, Hongui Cha, et al.
JCO Precision Oncology|October 5, 2020
Systematic Assessment of Tumor Purity and Its Clinical ImplicationsSyed Haider, Svitlana Tyekucheva, Davide Prandi, et al.
Gastroenterology|October 5, 2014
Association between molecular subtypes of colorectal cancer and patient survivalAmanda I Phipps, Paul J Limburg, John A Baron, et al.
Theranostics|May 1, 2019
Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA)Wenhua Liang, Yue Zhao, Weizhe Huang, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 16, 2011
Altered folate availability modifies the molecular environment of the human colorectum: implications for colorectal carcinogenesisPetr Protiva, Joel B Mason, Zhenhua Liu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 30, 2015
Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive TumorsA Joan Levine, Amanda I Phipps, John A Baron, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 7, 2011
Cancer risks for the relatives of colorectal cancer cases with a methylated MLH1 promoter region: data from the Colorectal Cancer Family RegistryA Joan Levine, Aung Ko Win, Daniel D Buchanan, et al.
Genome Research|June 11, 2011
Genome-scale analysis of aberrant DNA methylation in colorectal cancerToshinori Hinoue, Daniel J Weisenberger, Christopher P E Lange, et al.
Nature Genetics|November 29, 2011
Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domainsBenjamin P Berman, Daniel J Weisenberger, Joseph F Aman, et al.
International Journal of Cancer|January 7, 2009
The methylenetetrahydrofolate reductase C677T mutation induces cell-specific changes in genomic DNA methylation and uracil misincorporation: a possible molecular basis for the site-specific cancer risk modificationKyoung-Jin Sohn, Hyeran Jang, Mihaela Campan, et al.
Pageof 19